The finding of elevated ANRIL in the tumor when compared to normal adjacent tissue from the same donor irrespective of the subtype suggests ANRIL may be more universally increased in breast cancer, but the highest levels occur in triple negative tumors. The gene discussed is CDKN2B-AS1; the disease is breast carcinoma.